CF Foundation invests in breath test to detect Pseudomonas

CF Foundation invests in breath test to detect Pseudomonas

The Cystic Fibrosis Foundation will invest up to $2.3 million for a company to develop a breath test designed to detect Pseudomonas aeruginosa and to monitor chronic infections in people with cystic fibrosis (CF). P. aeruginosa bacteria are a major cause of lung disease in people with CF. Although it doesn’t typically cause illness in healthy people, the dense, sticky mucus in CF lungs creates an ideal environment for this bacteria to thrive and…